M1/M2-macrophage phenotypes regulate renal calcium oxalate crystal development

Scientific Reports

Volumn 6, Issue , 2016, Pages

  Taguchi, Kazumi ^a   Okada, Atsushi ^a   Hamamoto, Shuzo ^a   Unno, Rei ^a   Moritoki, Yoshinobu ^a   Ando, Ryosuke ^a   Mizuno, Kentaro ^a   Tozawa, Keiichi ^a   Kohri, Kenjiro ^a   Yasui, Takahiro ^a  

^a NAGOYA CITY UNIVERSITY GRADUATE SCHOOL OF MEDICAL SCIENCES   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CALCIUM OXALATE; CCL2 PROTEIN, MOUSE; CD44 PROTEIN, MOUSE; HYALURONIC ACID BINDING PROTEIN; MONOCYTE CHEMOTACTIC PROTEIN 1; OSTEOPONTIN; SPP1 PROTEIN, MOUSE;

ANIMAL; C57BL MOUSE; CELL ADHESION; CLASSIFICATION; COCULTURE; COMPLICATION; CRYSTALLIZATION; CYTOLOGY; GENE EXPRESSION; GENETICS; HYPEROXALURIA; KIDNEY TUBULE; MACROPHAGE; MALE; METABOLISM; MOUSE; NEPHROLITHIASIS; PATHOLOGY; PHENOTYPE; URINE;

ANIMALS; CALCIUM OXALATE; CELL ADHESION; CHEMOKINE CCL2; COCULTURE TECHNIQUES; CRYSTALLIZATION; GENE EXPRESSION; HYALURONAN RECEPTORS; HYPEROXALURIA; KIDNEY CALCULI; KIDNEY TUBULES; MACROPHAGES; MALE; MICE; MICE, INBRED C57BL; OSTEOPONTIN; PHENOTYPE;

EID: 84991101904     PISSN: None     EISSN: 20452322     Source Type: Journal    
DOI: 10.1038/srep35167     Document Type: Article

References (59)

1. Hernandez, J. D., Ellison, J. S., Lendvay, T. S. Current trends, evaluation, and management of pediatric nephrolithiasis. JAMA Pediatr. 169, 964-970 (2015).
2. Neisius, A., Preminger, G. M. Stones in 2012: epidemiology, prevention and redefining therapeutic standards. Nat Rev Urol. 10, 75-77 (2013).
3. Antonelli, J. A., Maalouf, N. M., Pearle, M. S., Lotan, Y. Use of the National Health and Nutrition Examination Survey to calculate the impact of obesity and diabetes on cost and prevalence of urolithiasis in 2030. Eur Urol. 66, 724-729 (2015).
4. Zisman, A. L., Evan, A. P., Coe, F. L., Worcester, E. M. Do kidney stone formers have a kidney disease? Kidney Int. 88, 1240-1249 (2015).
5. Ichikawa, J. et al. Increased crystal-cell interaction in vitro under co-culture of renal tubular cells and adipocytes by in vitro coculture paracrine systems simulating metabolic syndrome. Urolithiasis. 42, 17-28 (2014).
6. Zuo, L. et al. A paracrine mechanism involving renal tubular cells, adipocytes and macrophages promotes kidney stone formation in a simulated metabolic syndrome environment. J Urol. 191, 1906-1912 (2014).
7. Okada, A. et al. Genome-wide analysis of genes related to kidney stone formation and elimination in the calcium oxalate nephrolithiasis model mouse: detection of stone-preventive factors and involvement of macrophage activity. J Bone Miner Res. 24, 908-924 (2009).
8. Okada, A. et al. Renal macrophage migration and crystal phagocytosis via inflammatory-related gene expression during kidney stone formation and elimination in mice: Detection by association analysis of stone-related gene expression and microstructural observation. J Bone Miner Res. 25, 2701-2711 (2010).
9. Vervaet, B. A., Verhulst, A., Dauwe, S. E., De Broe, M. E., D'Haese, P. C. An active renal crystal clearance mechanism in rat and man. Kidney Int. 75, 41-51 (2009).
10. Grover, P. K., Thurgood, L. A., Fleming, D. E., van Bronswijk, W., Wang, T., Ryall, R. L. Intracrystalline urinary proteins facilitate degradation and dissolution of calcium oxalate crystals in cultured renal cells. Am J Physiol Renal Physiol. 294, F355-F361 (2008).
11. Mantovani, A., Sica, A., Sozzani, S., Allavena, P., Vecchi, A., Locati, M. The chemokine system in diverse forms of macrophage activation and polarization. Trends Immunol. 25, 677-686 (2004).
12. Murray, P. J. et al. Macrophage activation and polarization: nomenclature and experimental guidelines. Immunity. 41, 14-20 (2014).
13. Wang, Y., Harris, D. C. H. Macrophages in renal disease. J Am Soc Nephrol. 22, 21-27 (2011).
14. Nelson, P. J., Rees, A. J., Griffin, M. D., Hughes, J., Kurts, C., Duffield, J. The renal mononuclear phagocytic system. J Am Soc Nephrol. 23, 194-203 (2012).
15. Cao, Q. et al. Renal F4/80+ CD11c+ mononuclear phagocytes display phenotypic and functional characteristics of macrophages in health and in adriamycin nephropathy. J Am Soc Nephrol. 26, 349-363 (2015).
16. Zheng, D. et al. Transfused macrophages ameliorate pancreatic and renal injury in murine diabetes mellitus. Nephron Exp Nephrol. 118, e87-e99 (2011).
17. Cao, Q. et al. IL-25 induces M2 macrophages and reduces renal injury in proteinuric kidney disease. J Am Soc Nephrol. 22, 1229-1239 (2011).
18. Lee, S. et al. Distinct macrophage phenotypes contribute to kidney injury and repair. J Am Soc Nephrol. 22, 317-326 (2011).
19. Huang, Q. et al. IL-25 elicits innate lymphoid cells and multipotent progenitor type 2 cells that reduce renal ischemic/reperfusion injury. J Am Soc Nephrol. 26, 2199-2211 (2015).
20. Li, C. et al. Enhanced M1 and impaired M2 macrophage polarization and reduced mitochondrial biogenesis via inhibition of amp kinase in chronic kidney disease. Cell Physiol Biochem. 36, 358-372 (2015).
21. Nikolic-Paterson, D. J., Wang, S., Lan, H. Y. Macrophages promote renal fibrosis through direct and indirect mechanisms. Kidney Int Suppl. 4, 34-38 (2014).
22. Taguchi, K. et al. Proinflammatory and metabolic changes facilitate renal crystal deposition in an obese mouse model of metabolic syndrome. J Urol. 194, 1787-1796 (2015).
23. Taguchi, K. et al. Colony-stimulating factor-1 signaling suppresses renal crystal formation. J Am Soc Nephrol. 25, 1680-1697 (2014).
24. de Warer, R. et al. Calcium oxalate nephrolithiasis: effect of renal crystal deposition on the cellular composition of the renal interstitium. Am J Kidney Dis. 33, 761-771 (1999).
25. de Water, R. et al. Role of macrophages in nephrolithiasis in rats: an analysis of the renal interstitium. Am J Kidney Dis. 36, 615-625 (2000).
26. Umekawa, T., Hatanaka, Y., Kurita, T., Khan, S. Effect of angiotensin II receptor blockage on osteopontin expression and calcium oxalate crystal deposition in rat kidneys. J Am Soc Nephrol. 15, 635-644 (2014).
27. Khan, S. R. Reactive oxygen species as the molecular modulators of calcium oxalate kidney stone formation: evidence from clinical and experimental investigations. J Urol. 189, 803-811 (2013).
28. Fujii, Y. et al. Effect of adiponectin on kidney crystal formation in metabolic syndrome model mice via inhibition of inflammation and apoptosis. PLoS One. 8, e61343 (2013).
29. His, R. S. et al. Coronary artery calcium score and association with recurrent nephrolithiasis: the multi-ethnic study of atherosclerosis. J Urol. [Epub ahead of print] (2015).
30. Chi, T. et al. A Drosophila model identifies a critical role for zinc in mineralization for kidney stone disease. PLoS One. 10, e0124150 (2015).
31. Kusmartsev, S., Dominguez-Gutierrez, P. R., Canales, B. K., Bird, V. G., Vieweg, J., Khan, S. R. Calcium oxalate stone fragment and crystal phagocytosis by human macrophages. J Urol. [Epub ahead of print] (2015).
32. Khan, S. R., Canales, B. K. Genetic basis of renal cellular dysfunction and the formation of kidney stones. Urol Res. 37, 169-180 (2009).
33. Khan, S. R., Glenton, P. A. Experimental induction of calcium oxalate nephrolithiasis in mice. J Urol. 184, 1189-1196 (2010).
34. Joshi, S., Saylor, B. T., Wang, W., Peck, A. B., Khan, S. R. Apocynin-treatment reverses hyperoxaluria induced changes in NADPH oxidase system expression in rat kidneys: a transcriptional study. PLoS One. 7, e47738 (2012).
35. Niimi, K. et al. Mitochondrial permeability transition pore opening induces the initial process of renal calcium crystallization. Free Radic Biol Med. 52, 1207-1217 (2012).
36. Khan, S. R., Canales, B. K. Unified theory on the pathogenesis of Randall's plaques and plugs. Urolithiasis. 43, 109-123 (2015).
37. Evan, A. P. et al. Randall's plaque of patients with nephrolithiasis begins in basement membranes of thin loops of Henle. J Clin Invest. 111, 607-616 (2003).
38. Verkoelen, C. F., Verhulst, A. Proposed mechanisms in renal tubular crystal retention. Kidney Int. 72, 13-18 (2007).
39. Mulay, S. R. et al. Calcium oxalate crystals induce renal inflammation by NLRP3-mediated IL-1? secretion. J Clin Invest. 123, 236-246 (2013).
40. Kohri, K. et al. Biomolecular mechanism of urinary stone formation involving osteopontin. Urol Res. 40, 623-637 (2012).
41. Asselman, M., Verhulst, A., De Broe, M., Verkoelen, C. Calcium oxalate crystal adherence to hyaluronan-, osteopontin-, and CD44-expressing injured/regenerating tubular epithelial cells in rat kidneys. J Am Soc Nephrol. 14, 3155-3166 (2003).
42. Fairweather, D., Cihakova, D. Alternatively activated macrophages in infection and autoimmunity. J Autoimmun. 33, 222-230 (2009).
43. Cao, Q. et al. Failed renoprotection by alternatively activated bone marrow macrophages is due to a proliferation-dependent phenotype switch in vivo. Kidney Int. 85, 794-806 (2014).
44. Evan, A., Lingeman, J., Coe, F. L., Worcester, E. Randall's plaque: Pathogenesis and role in calcium oxalate nephrolithiasis. Kidney Int. 69, 1313-1318 (2006).
45. Randall, A. The origin and growth of renal calculi. Ann Surg. 105, 1009-1027 (1937).
46. Linnes, M. P. et al. Phenotypic characterization of kidney stone formers by endoscopic and histological quantification of intrarenal calcification. Kidney Int. 84, 818-825 (2013).
47. Letavernier, E. et al. Demographics and characterization of 10,282 randall plaque-related kidney stones. Medicine (Baltimore) 94, e566 (2015).
48. Lari, R. et al. Macrophage lineage phenotypes and osteoclastogenesis-complexity in the control by GM-CSF and TGF-? . Bone. 40, 323-336 (2007).
49. Fleetwood, A. J., Lawrence, T., Hamilton, J. A., Cook, A. D. Granulocyte-macrophage colony-stimulating factor (CSF) and macrophage CSF-dependent macrophage phenotypes display differences in cytokine profiles and transcription factor activities: Implications for CSF blockade in inflammation. J Immunol. 178, 5245-5252 (2007).
50. Hamers, A. A. et al. Bone marrow-specific deficiency of nuclear receptor Nur77 enhances atherosclerosis. Circ Res. 110, 428-438 (2012).
51. Chaiyarit, S., Thongboonkerd, V. Changes in mitochondrial proteome of renal tubular cells induced by calcium oxalate monohydrate crystal adhesion and internalization are related to mitochondrial dysfunction. J Proteome Res. 11, 3269-3280 (2012).
52. Okada, A. et al. Successful formation of calcium oxalate crystal deposition in mouse kidney by intraabdominal glyoxylate injection. Urol Res. 35, 89-99 (2007).
53. Honda, K., Yoshimura, M., Rao, T. N., Fujishima, A. Electrogenerated chemiluminescence of the ruthenium Tris(2,2')bipyridyl/amines system on a boron-doped diamond electrode. J Phys Chem B. 107, 1653-1663 (2003).
54. Muchamuel, T., Menon, S., Pisacane, P., Howard, M. C., Cockayne, D. A. IL-13 protects mice from lipopolysaccharide-induced lethal endotoxemia: correlation with down-modulation of TNF-alpha, IFN-gamma, and IL-12 production. J Immunol. 158, 2898-2903 (1997).
55. Whitman, S. C., Ravisankar, P., Elam, H., Daugherty, A. Exogenous interferon-? enhances atherosclerosis in apolipoprotein E-/-mice. Am J Pathol. 157, 1819-1824 (2000).
56. Tipping, P. G., Kitching, A. R., Huang, X. R., Mutch, D. A., Holdsworth, S. R. Immune modulation with interleukin-4 and interleukin-10 prevents crescent formation and glomerular injury in experimental glomerulonephritis. Eur J Immunol. 27, 530-537 (1997).
57. Jung, Y. J. et al. SIRT2 Regulates LPS-induced renal tubular CXCL2 and CCL2 expression. J Am Soc Nephrol. 26, 1549-1560 (2015).
58. Lee, M. W. et al. Activated type 2 innate lymphoid cells regulate beige fat biogenesis. Cell. 160, 74-87 (2015).
59. Pizzolato, P. Histochemical recognition of calcium oxalate. J Histochem Cytochem. 12, 333-336 (1964).